Journal of Internal Medicine Concepts & Practice >
Ectopic adrenocorticotropic hormone syndrome
ZHANG Cui, WANG Weiqing . Ectopic adrenocorticotropic hormone syndrome[J]. Journal of Internal Medicine Concepts & Practice, 2023 , 18(04) : 242 -246 . DOI: 10.16138/j.1673-6087.2023.04.006
[1] | Shepherd FA, Laskey J, Evans WK, et al. Cushing’s syndrome associated with ectopic corticotropin production and small-cell lung cancer[J]. J Clin Oncol, 1992, 10(1): 21-27. |
[2] | Winquist EW, Laskey J, Crump M, et al. Ketoconazole in the management of paraneoplastic Cushing’s syndrome secondary to ectopic adrenocorticotropin production[J]. J Clin Oncol, 1995, 13(1): 157-164. |
[3] | Zhang C, Jin J, Xie J, et al. The clinical features and molecular mechanisms of ACTH-secreting pancreatic neuroendocrine tumors[J]. J Clin Endocrinol Metab, 2020, 105(11): dgaa507. |
[4] | Isidori AM, Kaltsas GA, Pozza C, et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up[J]. J Clin Endocrinol Metab, 2006, 91(2): 371-377. |
[5] | Ilias I, Torpy DJ, Pacak K, et al. Cushing’s syndrome due to ectopic corticotropin secretion: twenty years’ experience at the National Institutes of Health[J]. J Clin Endocrinol Metab, 2005, 90(8): 4955-4962. |
[6] | Beuschlein F, Hammer GD. Ectopic pro-opiomelanocortin syndrome[J]. Endocrinol Metab Clin North Am, 2002, 31(1): 191-234. |
[7] | Newell-Price J, Bertagna X, Grossman AB, et al. Cushing’s syndrome[J]. Lancet, 2006, 367(9522): 1605-1617. |
[8] | Wang WQ, Ye L, Bi YF, et al. Six cases of ectopic ACTH syndrome caused by thymic carcinoid[J]. J Endocrinol Invest, 2006, 29(4): 293-297. |
[9] | Ye L, Li X, Kong X, et al. Hypomethylation in the promoter region of POMC gene correlates with ectopic overexpression in thymic carcinoids[J]. J Endocrinol, 2005, 185(2): 337-343. |
[10] | Li Y, Peng Y, Jiang X, et al. Whole exome sequencing of thymic neuroendocrine tumor with ectopic ACTH syndrome[J]. Eur J Endocrinol, 2017, 176(2): 187-194. |
[11] | Liu RX, Wang WQ, Ye L, et al. p21-activated kinase 3 is overexpressed in thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome and participates in cell migration[J]. Endocrine, 2010, 38(1): 38-47. |
[12] | Bi YF, Liu RX, Ye L, et al. Gene expression profiles of thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism[J]. Endocr Relat Cancer, 2009, 16(4): 1273-1282. |
[13] | Bi YF, Ye L, Chen YH, et al. Characteristics of ectopic adrenocorticotropic hormone syndrome due to thymic carcinoid and analysis of the molecular mechanism[J]. Chin Med J (Engl), 2008, 121(7): 667-670. |
[14] | Gewirtz G, Yalow RS. Ectopic ACTH production in carcinoma of the lung[J]. J Clin Invest, 1974, 53(4): 1022-1032. |
[15] | Jiang J, Li N, Wang X, et al. Aberrant expression and modification of silencing mediator of retinoic acid and thyroid hormone receptors involved in the pathogenesis of tumoral cortisol resistance[J]. Endocrinology, 2010, 151(8): 3697-3705. |
[16] | Nieman LK. Molecular derangements and the diagnosis of ACTH-dependent Cushing’s syndrome[J]. Endocr Rev, 2022, 43(5): 852-877. |
[17] | Reincke M, Ritzel K, O?wald A, et al. A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing’s syndrome[J]. Eur J Endocrinol, 2015, 173(4): M23-M32. |
[18] | Young J, Haissaguerre M, Viera-Pinto O, et al. Management of endocrine disease: Cushing’s syndrome due to ectopic ACTH secretion[J]. Eur J Endocrinol, 2020, 182(4): R29-R58. |
[19] | Guerrero-Pérez F, Peiró I, Marengo AP, et al. Ectopic Cushing’s syndrome due to thymic neuroendocrine tumours: a systematic review[J]. Rev Endocr Metab Disord, 2021, 22(4): 1041-1056. |
/
〈 |
|
〉 |